Fasudil

SKU: orb1745275

Description

Fasudil (HA-1077) is a cell-permeable, potent inhibitor targeting ROCK1, PKA, PKC, and MLCK kinases. It is widely used in cardiovascular and neurological research, demonstrating efficacy in both in vitro assays and in vivo models of vasospasm and neurodegeneration.

Research Area

Cell Biology, Epigenetics & Chromatin, Metabolism Research, Pharmacology & Drug Discovery, Signal Transduction, Stem Cell & Developmental Biology

Images & Validation

−

Key Properties

−

CAS Number	103745-39-7
MW	291.37
Purity	99.84% (May vary between batches)
Formula	C₁₄H₁₇N₃O₂S
SMILES	O=S(=O)(N1CCCNCC1)c1cccc2cnccc12
Target	Autophagy,PKA,PKC,Serine/threonin kinase,ROCK,Calcium Channel
Solubility	DMSO:61.875 mg/mL (212.36 mM)

Bioactivity

−

Target IC50	ROCK1:0.33 μM(Ki)\|ROCK2:0.158 μM\|MLCK:55 μM(Ki)\|PKC:9.3 μM(Ki)\|PKA:1.0 μM(Ki)\|PKG:1.65 μM
In Vivo	Fasudil (30 μg) produces an approximate 50% increase in CBF via intra-coronary injection to dogs. Fasudil (0.01, 0.03, 0.1 and 0.3 mg/kg, bolus, i.v.) dose-dependently decreases MBP and increases HR, VBF, CBF, RBF, and FBF. A total dose of 1.0 ng/mL Fasudil increases cardiac output. The infusion of Fasudil i.v. produces a significant fall in MBP, left ventricular systolic pressure and total peripheral resistance with an increase in HR and cardiac output, but without significant changes in right atrial pressure, dP/dt or left ventricular minute work in dogs. Fasudil administration displays protectable effects on cardiovascular disease and reduces the activation of JNK and attenuates mitochondrial-nuclear translocation of AIF under ischemic injury. The oral administration of Fasudil (a dosage of 100 mg/kg/day) significantly reduces incidence and mean maximum clinical score of EAE in SJL/J mice immunized with PLP p139-151. Treatment of mice with Fasudil suppresses the proliferative response of splenocytes to the antigen. Oral administration of Fasudil decreases inflammation, demyelination, axonal loss and APP positivein spinal cord of Fasudil-treated mice. Read more...
In Vitro	Fasudil (Hydrochloride) has vasodilatory action and occupies the adenine pocket of the ATP-binding site of the enzyme. Fasudil is a class of calcium antagonists. Fasudil produces a competitive inhibition of the Ca2+-induced contraction of the depolarized rabbit aorta. Fasudil is able to inhibit contractile responses to KCl, phenylephnne (PHE) and prostaglandin (PG) F2a. Fasudil also exhibits vasodilator actions by inhibition of 5-hydroxytryptamine, noradrenaline, histamine, angiotensin, and dopamine induced spiral strips contraction. Fasudil induces disorganization of actin stress fiber and cell migration inhibition. Fasudil inhibits hepatic stellate cells spreading, the formation of stress fibers, and expression of α-SMA with concomitant suppression of cell growth, but does not induce apoptosis. Fasudil suppresses the LPA-induced phosphorylation of ERK1/2, JNK and p38 MAPK. Read more...

Storage & Handling

−

Storage	store at low temperature \| Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice/Shipping at ambient temperature.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

Ca2+ channel antagonist, Ca2+ channels, Calcium Channel, Ca channels, Autophagy, AT 877, AT877, AT-877, a-SMA, collagen, CalciumChannel, lysophoaphatidic acid, LPA, MLCK, orally active, inhibit, JNK, ERK1/2, Fasudil, HA 1077, HA1077, HA-1077, Inhibitor, human HSC, p38, Serine kinase, threoninkinase, threonin kinase, Serinekinase, PKC, PKA, PKG, rat HSCs, TIMP-1, Protein kinase A, protein kinases, Protein kinase C, ROCK, ROCK2, ROK, Rho-kinase, Rho-associated protein kinase, Rho-associated kinase, TWNT-4 cells, vasodilator

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Compound Identifiers

PubChem CID

3547 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols

Fasudil (orb1745275)

Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

No reviews yet

Purity:	>99.99% (May vary between batches)
CAS Number:	105628-07-7
MW:	327.83
Formula:	C₁₄H₁₈ClN₃O₂S

CAS Number:	186694-02-0
MW:	673.67
Formula:	C₂₈H₃₈Cl₂N₆O₅S₂

CAS Number:	1001206-62-7
MW:	387.47
Formula:	C₁₅H₂₁N₃O₅S₂

Purity:	99.86%
CAS Number:	203911-27-7
MW:	364.29
Formula:	C₁₄H₁₉Cl₂N₃O₂S

Purity:	98.79%
CAS Number:	105628-72-6
MW:	307.37
Formula:	C₁₄H₁₇N₃O₃S

Fasudil

Description

Research Area

Images & Validation

Key Properties

Bioactivity

Storage & Handling

Alternative Names

Similar Products

Fasudil hydrochloride [orb1304579]

Fasudil hydrochloride hydrate [orb1739372]

Fasudil mesylate [orb2566273]

Fasudil dihydrochloride [orb1688655]

Hydroxyfasudil [orb1302996]

Quality Guarantee

Compound Identifiers

Key Properties

Documents Download

Request a Document

Protocol Information

Fasudil (orb1745275)

Step 1: Enter information below

Step 2: Enter the in vivo formulation

Available Sizes

Email

UK Office

US Office

CN Office

Distributors